
|Videos|January 13, 2015
How New Agents are Helping Address Clostridium Difficile-Associated Diarrhea Concerns
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
Advertisement
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
3
FDA Approves First Oral Drug for Dermatomyositis
4
FDA Grants Fast Track Designation to Varsetatug Masetecan for Metastatic Colorectal Cancer
5



































































































